on The Vanguard Group, Inc. (isin : US12572Q1058)
The Vanguard Group Discloses Stake in Mural Oncology plc
The Vanguard Group, Inc. has released Form 8.3, revealing its position in Mural Oncology plc as of May 1, 2025. The disclosure is in accordance with Rule 8.3 of the Irish Takeover Panel Act of 1997, detailing holdings in Mural Oncology's securities. Vanguard holds 772,705 ordinary shares, representing a 4.47% stake in the company.
Additionally, it has made a recent purchase of 18 ordinary shares at USD 2.61 per unit. Currently, Vanguard has not participated in any derivative transactions or entered into indemnity agreements related to Mural Oncology's securities. The disclosure clarifies that no supplemental Form 8 is attached, and no other parties are implicated in the offer.
R. E.
Copyright © 2025 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all The Vanguard Group, Inc. news